ArticleEuropean journal of clinical pharmacology2020

Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan.

Yukyung Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.